
IFF (NYSE:IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global

<p xmlns="http://www.w3.org/1999/xhtml">
IFF (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IFF">IFF</a>) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, including its range of natural colors and antioxidants and certain localized flavor activities in Peru.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The portfolio serves a broad range of food, beverage and nutritional end markets through a comprehensive selection of customized solutions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne," said Erik Fyrwald, CEO IFF. "This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health &amp; Biosciences — where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders."

</p><p xmlns="http://www.w3.org/1999/xhtml">
The transaction includes operations that generated revenues of approximately $170 million in 2025. Collectively, the activities included in the transaction employ about 600 people and operate across five manufacturing facilities in Europe, the United States and Latin America. Financial terms of the deal were not disclosed.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The companies expect to close the sale by the end of 2026, subject to customary closing conditions, including regulatory clearances and the satisfaction of applicable consultation requirements. Alantra acted as financial advisor to IFF and DLA Piper LLP acted as legal counsel.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Cautionary Statement under the Private Securities Litigation Reform Act of 1995</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release contains "forward-looking statement" within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the transaction and the expected timetable for completing the transaction. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Welcome to IFF
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>At IFF (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IFF">IFF</a>), we make joy through science, creativity and heart. As the global leader in taste, scent, and health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iff.com%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=iff.com&amp;index=1&amp;md5=2da0f0ddb12c89bdf4690761d68d7899" shape="rect">iff.com</a>, <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fiff%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=f7d9d0eb3fba1ef6b9cdfd2dd4c96b2d" shape="rect">LinkedIn</a>, <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fiffinc%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=Instagram&amp;index=3&amp;md5=6736eab7c7b9af51dab7ca643ca71728" shape="rect">Instagram</a> and <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FInternationalFlavorsandFragrances%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=Facebook&amp;index=4&amp;md5=de13d65fb161318226c9f92468bed4b5" shape="rect">Facebook</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
&#xA9; 2026 by International Flavors &amp; Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260720583488r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260720583488/en/" rel="nofollow">https://www.businesswire.com/news/home/20260720583488/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Media Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Jennifer McGowan
<br xmlns="http://www.w3.org/1999/xhtml"></br>848.358.1680
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Media.request@iff.com" shape="rect">Media.request@iff.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Investor Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Michael Bender
<br xmlns="http://www.w3.org/1999/xhtml"></br>212.708.7263
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Investor.Relations@iff.com" shape="rect">Investor.Relations@iff.com</a>

</p>

IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

IFF to divest Peru portfolio to SuanNutra, refocusing on core units

MADRID, July 20, 2026 /PRNewswire/ -- SuanNutra, a global provider of science-backed branded and functional ingredients, and Carbyne Equity Partners today announced that SuanNutra has signed an agreement to acquire a

SuanNutra, a Carbyne Equity Partners Portfolio Company, Expands Product Portfolio with Specialty Natural Ingredients Businesses from IFF

<section class="insight" data-version="1">
  <section data-block="information">
    <h3>Information</h3>
    <p>IFF (NYSE:IFF) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global</p>
  </section>

  <section data-block="ai-summary-paragraph">
    <h3>AI Summary</h3>
    <p>IFF will divest its Peru-based portfolio of botanical extracts, natural colors, and related flavor activities to SuanNutra, a Carbyne Equity Partners portfolio company. The move supports portfolio optimization and a sharper focus on core Taste, Scent, and Health &amp; Biosciences. The assets generated about $170 million in 2025 with roughly 600 employees across five facilities; closing is expected by end-2026.</p>
  </section>

  <section data-block="ai-summary-bullets">
    <h3>Key Points</h3>
    <ul><li>IFF to sell Peru portfolio of botanicals, colors, and flavors to SuanNutra/Carbyne.</li><li>Assets generated about $170 million in 2025; 600 employees across 5 facilities.</li><li>Closing expected by end-2026, subject to regulatory clearances.</li><li>Terms of the deal were not disclosed.</li><li>Management cites portfolio optimization to focus on core Taste, Scent, Health &amp; Biosciences.</li></ul>
  </section>

  <section data-block="companies-mentioned">
    <h3>Companies Mentioned</h3>
    <ul><li><strong>SuanNutra (N/A)</strong>: Buyer; portfolio company of Carbyne Equity Partners, acquiring Peru assets.</li><li><strong>Carbyne Equity Partners (N/A)</strong>: Owner of SuanNutra; involved in deal structuring and funding.</li><li><strong>Alantra (N/A)</strong>: Financial advisor to IFF for the transaction.</li><li><strong>DLA Piper LLP (N/A)</strong>: Legal counsel for IFF; handling closing conditions.</li></ul>
  </section>

  <section data-block="category">
    <h3>M&amp;A</h3>
    <p>Strategic corporate development with an M&amp;A flavor; aligns with IFF’s portfolio-pruning strategy to emphasize core innovation-led segments.</p>
  </section>

  <section data-block="market-moving">
    <h3>Market-Moving</h3>
    <ul><li>Closing by end-2026 is contingent on regulatory clearances.</li><li>The sale sharpens IFF’s focus on core businesses: Taste, Scent, Health &amp; Biosciences.</li><li>Terms are undisclosed, creating near-term earnings ambiguity.</li></ul>
  </section>

  <section data-block="key-facts">
    <h3>Key Facts</h3>
    <ul><li>2025 revenue from assets: approximately $170 million.</li><li>Headcount: about 600 employees.</li><li>Facilities: five manufacturing sites across Europe, the US, and Latin America.</li><li>Closing target: by end-2026; subject to regulatory approvals and consultations.</li></ul>
  </section>

  <section data-block="trading-thesis">
    <h3>Trading Thesis</h3>
    <p>Neutral near-term; divestiture could improve cash flow and optionality for deleveraging or buybacks.</p>
  </section>
</section>


<p xmlns="http://www.w3.org/1999/xhtml">
IFF (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IFF">IFF</a>) — a global leader in flavors, fragrances, and health and biosciences — today announced that it has entered into an agreement with SuanNutra, a Carbyne Equity Partners portfolio company and global provider of science-backed branded and functional ingredients, to sell its portfolio of botanical extracts, vitamins and minerals, and food enhancement activities, including its range of natural colors and antioxidants and certain localized flavor activities in Peru.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The portfolio serves a broad range of food, beverage and nutritional end markets through a comprehensive selection of customized solutions.

</p><p xmlns="http://www.w3.org/1999/xhtml">
"These businesses are highly respected, and we are confident they will continue to thrive under the ownership of SuanNutra and Carbyne," said Erik Fyrwald, CEO IFF. "This transaction is another step in optimizing our portfolio and reinforces our focus on our core innovation-led businesses — Taste, Scent and Health &amp; Biosciences — where we see the greatest opportunities to drive long-term profitable growth and create value for our shareholders."

</p><p xmlns="http://www.w3.org/1999/xhtml">
The transaction includes operations that generated revenues of approximately $170 million in 2025. Collectively, the activities included in the transaction employ about 600 people and operate across five manufacturing facilities in Europe, the United States and Latin America. Financial terms of the deal were not disclosed.

</p><p xmlns="http://www.w3.org/1999/xhtml">
The companies expect to close the sale by the end of 2026, subject to customary closing conditions, including regulatory clearances and the satisfaction of applicable consultation requirements. Alantra acted as financial advisor to IFF and DLA Piper LLP acted as legal counsel.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Cautionary Statement under the Private Securities Litigation Reform Act of 1995</b>

</p><p xmlns="http://www.w3.org/1999/xhtml">
This press release contains "forward-looking statement" within the meaning of the federal securities laws, including Section 27A of the Securities Act, and Section 21E of the Securities Exchange Act of 1934, as amended (the "Exchange Act"). Forward-looking statements often address expected future business and financial performance and financial condition, and often contain words such as "expect," "anticipate," "intend," "plan," "believe," "seek," "see," "will," "would," "target," similar expressions, and variations or negatives of these words. Forward-looking statements by their nature address matters that are, to different degrees, uncertain, such as statements about the transaction and the expected timetable for completing the transaction. The forward-looking statements included in this release are made only as of the date hereof, and we undertake no obligation to update the forward-looking statement to reflect subsequent events or circumstances.

</p><p xmlns="http://www.w3.org/1999/xhtml">
<b xmlns="http://www.w3.org/1999/xhtml">Welcome to IFF
<br xmlns="http://www.w3.org/1999/xhtml"></br></b>At IFF (NYSE:<a class="ticker" href="https://www.benzinga.com/quote/IFF">IFF</a>), we make joy through science, creativity and heart. As the global leader in taste, scent, and health and biosciences, we’re innovating for the future. Every day, we deliver groundbreaking, sustainable solutions that elevate products people love — advancing wellness, delighting the senses and enhancing the human experience. Learn more at <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.iff.com%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=iff.com&amp;index=1&amp;md5=2da0f0ddb12c89bdf4690761d68d7899" shape="rect">iff.com</a>, <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fiff%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=LinkedIn&amp;index=2&amp;md5=f7d9d0eb3fba1ef6b9cdfd2dd4c96b2d" shape="rect">LinkedIn</a>, <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.instagram.com%2Fiffinc%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=Instagram&amp;index=3&amp;md5=6736eab7c7b9af51dab7ca643ca71728" shape="rect">Instagram</a> and <a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.facebook.com%2FInternationalFlavorsandFragrances%2F&amp;esheet=54573376&amp;newsitemid=20260720583488&amp;lan=en-US&amp;anchor=Facebook&amp;index=4&amp;md5=de13d65fb161318226c9f92468bed4b5" shape="rect">Facebook</a>.

</p><p xmlns="http://www.w3.org/1999/xhtml">
&#xA9; 2026 by International Flavors &amp; Fragrances Inc. IFF is a Registered Trademark. All Rights Reserved.

</p><p xmlns="http://www.w3.org/1999/xhtml"><img xmlns="http://www.w3.org/1999/xhtml" alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20260720583488r1&amp;sid=benz2&amp;distro=nx&amp;lang=en" style="width:0;height:0"></img><span xmlns="http://www.w3.org/1999/xhtml" class="bwct31415"></span></p><p xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink"><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-phrase">View source version on businesswire.com: </span><span xmlns="http://www.w3.org/1999/xhtml" id="mmgallerylink-link"><a xmlns="http://www.w3.org/1999/xhtml" href="https://www.businesswire.com/news/home/20260720583488/en/" rel="nofollow">https://www.businesswire.com/news/home/20260720583488/en/</a></span></p><p xmlns="http://www.w3.org/1999/xhtml">
Media Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Jennifer McGowan
<br xmlns="http://www.w3.org/1999/xhtml"></br>848.358.1680
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Media.request@iff.com" shape="rect">Media.request@iff.com</a>

</p><p xmlns="http://www.w3.org/1999/xhtml">
Investor Relations:
<br xmlns="http://www.w3.org/1999/xhtml"></br>Michael Bender
<br xmlns="http://www.w3.org/1999/xhtml"></br>212.708.7263
<br xmlns="http://www.w3.org/1999/xhtml"></br><a xmlns="http://www.w3.org/1999/xhtml" rel="nofollow" href="mailto:Investor.Relations@iff.com" shape="rect">Investor.Relations@iff.com</a>

</p>

IFF will divest its Peru-based portfolio of botanical extracts, natural colors, and related flavor activities to SuanNutra, a Carbyne Equity Partners portfolio company. The move supports portfolio optimization and a sharper focus on core Taste, Scent, and Health & Biosciences. The assets generated about $170 million in 2025 with roughly 600 employees across five facilities; closing is expected by end-2026.

iff-announces-agreement-to-sell-its-portfolio-of-botanical-extracts-vitamins-minerals-and-food-enhancement-activities-to-suannutra-a-portfolio-company-of-carbyne-equity-partners

IFF Announces Agreement to Sell Its Portfolio of Botanical Extracts, Vitamins & Minerals and Food Enhancement Activities to SuanNutra, a Portfolio Company of Carbyne Equity Partners.

AI Summary

Sentiment Rationale

Trading Thesis

Market-Moving

Key Facts

Companies Mentioned

M&A

Related News